1 Section of Health Technology Assessment and Erasmus Choice Modelling Centre, Institute of Health Policy and Management, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR, Rotterdam, The Netherlands. debekker-grob@bmg.eur.nl.
2 Section of Medical Decision Making and Erasmus Choice Modelling Centre, Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands. debekker-grob@bmg.eur.nl.
3 Novartis Pharma AG, Basel, Switzerland.
4 Janssen R&D LLC, Titusville, NJ, USA.
5 Rheumatology Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
6 Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK.
7 European Cancer Patient Coalition, Brussels, Belgium.
8 Belgian Health Care Knowledge Centre, Brussels, Belgium.
9 Diagnóza Leukemie, Prague, Czech Republic.
10 Federal Institute for Drugs and Medical Devices, Bonn, Germany.
11 Department of Public Health and Caring Sciences, Centre for Research Ethics and Bioethics, Uppsala University, Uppsala, Sweden.